Medical Professionals
Many GRE diseases cause variable and systemic health problems, thus can be very difficult to diagnose. For example, childhood onset of Myotonic Dystrophy often takes 7-9 years to diagnose, and adult onset is often never diagnosed. 3X Genetics works with medical professionals to increase awareness of GRE diseases and to accelerate patient discovery by providing diagnostic and genetic counseling services.
Therapeutic Companies
More than one hundred companies are developing therapeutics for GRE diseases, including ARTHEx Biotech, Avidity Biosciences, Design Therapeutics, Dyne Therapeutics, Entrada Therapeutics, PepGen, Vertex Pharmaceuticals, and many others. 3X Genetics partners with therapeutic companies to accelerate patient discovery by offering low-cost testing and sponsored no-cost testing for families of GRE patients.
Foundations and Clinics
3X Genetics partners with foundations and clinics to support verified GRE patients and their families with diagnostic testing and monitoring services and predictive health guidance via AI-driven correlation of patient symptoms and age of onset with repeat expansion data. We also seek to work with foundations and clinics to advance scientific discovery by sharing de-identified patient data with researchers and therapeutic companies.
3x Genetics Inc. 17 Briden Street. Suite 105, Worcester, MA 01605 (c) 3X Genetics Inc. 2024. All Rights Reserved.